(S)-2-BENZYL-4-(TERT-BUTOXY)-4-OXOBUTANOIC ACID, 95.0%, 250mg

L-(+)-Tartaric acid, 99.0%, 2.5kg

2-Cyano-5-nitrobenzotrifluoride, 98.0%, 1g

4-(2-thienyl)-1H-imidazole, 95.0%, 250mg

(R)-N-(Piperidin-3-yl)pyridine-4-carboxamide dihydrochloride, 95.0%, 1g

2-(2,4-Dichlorobenzyl)-1H-benzo[d]imidazole, 95.0%, 100g

4-Bromo-2,6-dichloropyridine, 95.0%, 5g

Propylene glycol monoethyl ether, min 99%, for synthesis, 5L, plastic packaging.

3-BROMO-1H-INDAZOLE-7-CARBOXYLIC ACID, 98%, 1g

6,10-Dioxaspiro[4.5]decane-7,9-dione, 95.0%, 1g

N,N-Dimethylformamide Dipropyl Acetal [for Esterification]>90.0%(T)25mL

5-(3-bromophenyl)-4-phenyl-4H-1,2,4-triazole-3-thiol, 10g

6-Fluoro-1-methylindolin-2-one, 97%, 100mg